Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Research uncovers hidden Australian skin cancer epidemic

2.

Chemo-Free Regimen for Ph+ ALL Yields High Rate of Deep MRD Negativity

3.

Reasons Behind Refusing Stem Cell Transplantation in Certain Myeloma Patients.

4.

Experts Discuss Groundbreaking Advances in EGFR-Mutant Lung Cancer

5.

Short-course radiation matches standard therapy for endometrial cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot